Results 161 to 170 of about 1,219,792 (316)

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT

, 2010
Ken Ishiyama, Takamasa Katagiri, Takumi Hoshino, Takashi Yoshida, Masaki Yamaguchi, Shinji Nakao   +5 more
openalex   +2 more sources

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

Clinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Venanprubart (LY3361237), an agonist antibody to B and T lymphocyte attenuator (BTLA), was developed as a potential treatment for autoimmune disorders, including systemic lupus erythematosus (SLE) and psoriasis. We tested venanprubart in three human Phase 1 safety studies: a single ascending dose (SAD) study in healthy participants (1/2/5/15 ...
Andrew C. Vendel, Olivier Benichou, Ching‐Yun Chang, Gourab Datta, Andrea Ferrante, Indrajit Ghosh, Brian A. Moser, Susan E. Sweeney, Jennifer Witcher, Matthew D. Linnik   +9 more
wiley   +1 more source

Human herpesvirus 6 (HHV-6) infection and risk of Alzheimer's disease: a systematic review and meta-analysis. [PDF]

BMC Neurol
Bastan F, Saeedi-Moghaddam F, Rashidian M, Mirhosseini F, Mozhgani SH.   +4 more
europepmc   +1 more source

Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients. [PDF]

Blood Adv, 2023
Noviello M, Lorentino F, Xue E, Racca S, Furnari G, Valtolina V, Campodonico E, Dvir R, Lupo-Stanghellini MT, Giglio F, Piemontese S, Clerici D, Oltolini C, Tassi E, Beretta V, Farina F, Mannina D, Ardemagni A, Vago L, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Bonini C, Greco R.   +25 more
europepmc   +1 more source

The putative U94 integrase is dispensable for human herpesvirus 6 (HHV-6) chromosomal integration.

Journal of General Virology, 2016
Nina Wallaschek, A. Gravel, L. Flamand, B. Kaufer   +3 more
semanticscholar   +1 more source

Correction for Strong et al., Epstein-Barr Virus and Human Herpesvirus 6 Detection in a Non-Hodgkin's Diffuse Large B-Cell Lymphoma Cohort by Using RNA Sequencing [PDF]

, 2015
Michael J. Strong, Tina O’Grady, Zhen Lin, Guorong Xu, Melody Baddoo, Chris Parsons, Kun Zhang, Christopher M. Taylor, Erik K. Flemington   +8 more
openalex   +1 more source

Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT Primary effusion lymphoma (PEL) is a rare and aggressive B‐cell non‐Hodgkin lymphoma (NHL) that predominantly affects patients with human immunodeficiency virus infection and is strongly associated with human herpes virus 8 (HHV‐8) infection. Due to its rarity, the current understanding of PEL's epidemiology and management is largely derived ...
John L. Vaughn, Gardenia Taza, Malak Munir, Sravani Rimmalapudi, Narendranath Epperla   +4 more
wiley   +1 more source

Human Herpesvirus-6 Infectious Meningitis With Lymphadenitis in an Immunocompetent Adult. [PDF]

Brain Behav
Xie Y, Zhang C, Ma M, Yin Z, Chen L, Yang Y, Wu S, Fan Y, Xu Y, He D.   +9 more
europepmc   +1 more source

The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease

Journal of Clinical Laboratory Analysis, Volume 40, Issue 1, January 2026.
Bacterial and viral pathogens may play a key role in Behçet's disease (BD) pathogenesis by triggering autoimmunity, molecular mimicry, or microbiome disruption. These infectious agents could initiate inflammatory pathways, contributing to BD's diverse clinical manifestations.
Mohsen Moghoofei, Hamid Pajavand, Razieh Shahbazi, Marzieh Rezaei, Elahe Taki   +4 more
wiley   +1 more source

Clinical and laboratory features of human herpesvirus 6 chromosomal integration.

Clinical Microbiology and Infection, 2016
Duncan A. Clark
semanticscholar   +1 more source